Vibrant Therapeutics raised $61 million and appointed Han Lee, Ph.D. as Co-CEO.
- Amount
- $61M
- Announced
- 12 January 2026
- Investors
- Pfizer Ventures, Apricot Capital, Bayland Capital, HongShan Capital Group, Northern Light Venture Capital, First Principle Venture Limited
- Use of funds
- To advance the pipeline, further develop its drug design platform, and expand the team for global development.
- Total raised
- $100M to date
- Checked
- Amount and date checked against the press source